NautaDutilh assists sellers on the auction sale of Batavia Biosciences

NautaDutilh assisted Batavia Biopharma and First Dutch investments on the sale of a majority interest (ca. 75%) in Leiden based Batavia Biosciences B.V. for approximately EUR 195 million to Korea based CJ Corp.

Batavia is a CDMO (Contract Development and Manufacturing Organization) the field of viral vector based biotherapeutics.

“It was a challenging auction process with many stakeholders, but with a great result for all involved”

Partner Ruud Smits

Ruud Smits: “This was a great team effort from our NY and Amsterdam based life sciences teams. It was a challenging auction process with many stakeholders, but with a great result for all involved. Given the type of business foreign direct investment approvals play an important role.”

Our team consisted of: Ruud Smits, Jeanine Evertse, Jos Somers, Willem vd Vossen, Nima Lorje, Arnout Koeman, Jasmijn van Koetsveld, Wijnand Bossenbroek, Florine Kuiperi, Frans Ruijs, Pedro Paraguay and Jeroen Boelens.

Het Financieele Dagblad: Koreanen kopen Batavia biosciences voor bijna 200 miljoen
Korea Economic Daily: CJ Cheiljedang to buy Dutch firm Batavia Biosciences for 195 million euros
Econotimes: Korea’s CJ Cheiljedang to buy Dutch firm Batavia Biosciences for $226M
Biopharma Reporter: CJ Cheiljedang set to acquire Batavia Biosciences for $226m

NautaDutilh assists sellers on the auction sale of Batavia Biosciences

Related articles

NautaDutilh represents Uber with its investment in Moove's Series B round

NautaDutilh assists Blossom Capital with Series A+ investment in TheyDo

Life Sciences challenges and opportunities in Europe and the USA: key insights

Inhibiting the plausibility doctrine: Dutch Court of Appeal rules on evidence standard for inventive step after G2/21

NautaDutilh advises NewAmsterdam Pharma on USD 726 million business combination with Frazier Lifesciences Acquisition Corp.

NautaDutilh assisted Ginkgo Bioworks on its acquisition of Dutch DNA Biotech

NautaDutilh assisted LUMICKS Technologies with its $93M Series D Financing

NautaDutilh assisted Arvelle Therapeutics on its acquisition by Angelini Pharma

NautaDutilh assisted Pharvaris B.V. with its $80M Series C Financing

NautaDutilh assists Sanofi with public offer for Kiadis Pharma

NautaDutilh assisted the investor consortium led by Novo Holdings in a Series A financing round of The Protein Brewery

Vinted and United Wardrobe are joining forces. NautaDutilh assists Vinted with the acquisition of United Wardrobe

NautaDutilh assisted investor consortium including Novo Ventures in a $83 million Series C financing round by LAVA Therapeutics B.V.

Salvia Bioelectronics raises EUR 26 million from investor consortium

NautaDutilh assists CureVac on the private financing round, IPO and private placement

NautaDutilh successfully assisted VarmX in its EUR 32M oversubscribed Series B financing round

NautaDutilh assists BlueBee on its sale to Illumina Inc.

CJEU rules that free samples of OTC medicinal products can be provided to pharmacists

NautaDutillh assisted Forbion in a $62.5M Series A financing round by Prilenia Therapeutics B.V.

NECSTGEN: 4000 square meters for stem cell research, NautaDutilh advises.

Government relief for start-ups and scale-ups

Notification de cookies